Overview

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
A preliminary study to test how florbetapir F 18 (18F-AV-45) acts in the brains and bodies of healthy elderly people and patients with Alzheimer's Disease (AD) by using a positron emission tomography (PET) scanner.
Phase:
Early Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals